TakeoverPE & activists

PSNLPersonalis, Inc.

Services-Medical Laboratories · $1.7B market cap · 260 employees

1.8×

More likely than average to be taken private

Top 7% of the Russell 3000 for a buyout by a private-equity firm, holdco or insiders. How it works

Takeover signals

What an activist or buyer would see: cheap, overpaid, diluted or under pressure.

3of 15 firedHow well they predict deals →
12 other checks
  • TSR below peersNo
    —
    3+ of last 5 years
  • High CEO pay despite TSRNo
    —
    Median CEO pay ≥ $15M while TSR trails
  • Earnings not backed by cashNo
    —
    Cash flow under 80% of net income
  • Payouts exceed cash flowNo
    0% of cash flow
    Buybacks + dividends over cash flow
  • Goodwill-heavyNo
    —
    Over 40% of assets
  • Shareholder dissentNo
    90% lowest support
    Any vote under 80% support
  • Low revenue per employeeNo
    $268K · 56th pct
    Bottom quartile of its SIC industry
  • Quiet on AINo
    2.3 per 10K words · 59th pct
    Bottom quartile of AI mentions in 10-Ks
  • Net cashNo
    —
    More cash than debt, positive EBITDA
  • Recurring revenueNo
    —
    10-K business scored 7+ of 10 for recurring revenue
  • AI-rollup shapedNo
    —
    10-K business scored 5+ of 10 as an AI-rollup target
  • Net insider sellingNo
    −$6M net
    Net sales over $10M in 12 months

Deal filings

FiledFormAcquirerPricePremium
Oct 21, 2026DEFM14ATempus AI, Inc.$16.2511%
Oct 20, 2026SC 13E3/ATempus AI, Inc.——
Oct 2, 2026SC 13E3/ATempus AI, Inc.——
Aug 31, 2026SC 13E3Tempus AI, Inc.——
Jul 20, 20268-KTempus AI, Inc.——

Key numbers

Revenue
$70MFY2021: $85MFY2022: $65MFY2023: $73MFY2024: $85MFY2025: $70M
18% YoY
Operating margin
-126.4%FY2021: -76.4%FY2022: -177.6%FY2023: -149.6%FY2024: -80.7%FY2025: -126.4%
57% YoY
EBITDA
−$78MFY2021: −$59MFY2022: −$107MFY2023: −$99MFY2024: −$57MFY2025: −$78M
36% YoY
Net debt / EBITDA
—
−$94M net debt

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$85M$65M$73M$85M$70M 18% FY2021: $85MFY2022: $65MFY2023: $73MFY2024: $85MFY2025: $70M
Operating income−$65M−$116M−$110M−$68M−$88M 29% FY2021: −$65MFY2022: −$116MFY2023: −$110MFY2024: −$68MFY2025: −$88M
Net income−$65M−$113M−$108M−$81M−$81M 0.0% FY2021: −$65MFY2022: −$113MFY2023: −$108MFY2024: −$81MFY2025: −$81M
Operating cash flow−$71M−$70M−$56M−$45M−$75M 66% FY2021: −$71MFY2022: −$70MFY2023: −$56MFY2024: −$45MFY2025: −$75M
Capex$11M$50M$11M$2M$5M 181% FY2021: $11MFY2022: $50MFY2023: $11MFY2024: $2MFY2025: $5M
Stock-based comp$14M$19M$14M$11M$9M 12% FY2021: $14MFY2022: $19MFY2023: $14MFY2024: $11MFY2025: $9M

13D filers

FiledFilerFormStakeIntent
Jul 21, 2026Tempus AI, Inc.SCHEDULE 13D/A12.5%Active
Jun 10, 2026Lightspeed Venture Partners Select IV, L.P.SCHEDULE 13D/A2.0%Passive
Sep 12, 2025Tempus AI, Inc.SCHEDULE 13D/A14.5%Passive
Aug 20, 2024Tempus AI, Inc.SC 13D/A19.3%Passive
Jul 3, 2024Tempus AI, Inc.SC 13D33.4%Passive
Jun 28, 2024LIGHTSPEED VENTURE PARTNERS VIII LPSC 13D/A—Passive
Mar 7, 2022LIGHTSPEED VENTURE PARTNERS VIII LPSC 13D/A9.2%Passive
Aug 24, 2020LIGHTSPEED VENTURE PARTNERS VIII LPSC 13D12.9%Passive

Insider trading

−$6Mnet selling by insiders, open market, last 12 months
Bought $3M · 12 tradesSold $9M · 15 trades

Pay vs performance

No pay-versus-performance disclosure yet.